Medical Device Network on MSN3d
Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenueDexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...
The warning letter follows inspections by the FDA at Dexcom’s manufacturing facilities in San Diego and Mesa, Ariz., and ...
The Trump administration shut down two critical food safety committees, cutting off expert advice to the USDA, FDA, and CDC.
If drug tariffs don’t work, they could result in higher prices for American patients and increase drug shortages. Testing ...
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.
Pharmaceutical company Alkem Laboratories Ltd on Thursday (March 13) announced that the United States Food and Drug ...
A California company's dried lily flowers have been recalled because they may contain undeclared sulfites, according to the U.S. Food and Drug Administration. The FDA and Hayward, California-based ...
IPA also stated that while generics are priced lower than the corresponding brands, it is unfair and unacceptable to link quality with cost.
In a regulatory filing, DexCom (DXCM) disclosed that on March 4, the company received a warning letter from the U.S. FDA following inspections ...
The fall in the share price came after the company announced that its Clinical Research Organisation, AnaCipher, located at ...
Symbiosis Pharmaceutical Services has completed the latest inspection by the U.S. FDA of its facilities in Scotland.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback